APHP, hopital Bichat
Paris, 75018, France
NCT Number: NCT00338234
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation.
Looking for future studies?
Notify Me20 year–88 year
All sexes
Observational
Paris, 75018, France
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation. The latter is known to interfere with iron metabolism, inducing iron storage instead of using it for hemoglobin synthesis. The discover of a new regulatory hormone of iron metabolism, hepcidin, may help us to better understand the link between inflammation and iron functional deficit. The aim of our study is to observe the variation of usual iron metabolism biological markers and of hepcidin, in order to define the better marker of iron loss in these clinical situations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: during the study
Time frame: at one day,at seven days and at 28 days
Assistance Publique - Hôpitaux de Paris
Other
Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients, Role of Hepcidin
Acronym: FAIRe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07092683
Anemia, Behavior
Hangzhou, Zhejiang, China
View Trial DetailsNCT04980911
Anemia, Cardiac Surgery
Metz, Moselle, France
View Trial DetailsNCT00944112
Anemia, Blood Transfusion
Dundee, United Kingdom
View Trial DetailsNCT07671469
Anemia, Blood Transfusion
Palo Alto, California, United States
View Trial Details